Unicon Investment has recommended hold rating on Lupin Pharmaceuticals with a target price of Rs 520, in its November 12, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!